Merck & Co. (MRK)

EBITDA Growth

-77.81%

Quarterly · Period ending:

MRK logo

MRK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-77.81%
MRK Quarterly EBITDA YoY % (23.12% → -77.81%)
High-resolution chart · PNG

MRK ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Merck & Co. EBITDA Growth — Quarterly
Period endingEBITDA Growth
4.2997%
8.8988%
30.6559%
21.6046%
19.2858%
16.6147%
13.8872%
-3.8567%
38.3191%
38.0939%
-14.1913%
59.7978%
4.1265%
6.4557%
12.3667%
8.7047%
14.5143%
19.303%
16.304%
10.9701%
9.9719%
9.7396%
1.0631%
0.1899%
-2.8337%
-0.3473%
0.6023%
20.3299%
486.4878%
16.4214%
112.9195%
12.724%
-77.203%
6.9301%
6.3607%
12.9555%
5.8389%
5.8614%
15.6909%
17.3048%
26.3347%
30.4961%
22.7552%
16.2526%
-56.0434%
-61.6457%
121.76%
-60.5392%
5.6941%
9.368%
-10.4844%
12.4225%
20.0512%
29.3133%
-18.5237%
23.9916%
24.3085%
20.6275%
-10.7961%
23.1246%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.